Drug Approval | July 17, 2025
SMS Lifesciences India receives EIR with VAI status from USFDA for API facility at Kazipally
The receipt of EIR reaffirms the company's commitment to maintaining global quality standards
The receipt of EIR reaffirms the company's commitment to maintaining global quality standards
Plant-based chemistries have an outsized role to play for the HPC sector by meeting demand for good, gentle, and green products
Godavari Biorefineries receives patent from CNIPA
The agreement includes plans for distribution, technology transfer, local manufacturing, new pharmaceutical product development
Capricor’s BLA for Deramiocel received Priority Review in March 2025
Havix is a US based company engaged in the business of developing, manufacturing and supplying of various finished formulations
The company’s largest center for medical device applications, serving the entire Asian market
Emcure Pharmaceuticals successfully completes USFDA PAI of Oncology facility
This year, 40 women students are participating, selected through a rigorous process evaluating academic merit, research interest, and socio-economic background
Takara Bio Europe will distribute MN’s Bioanalysis portfolio in Austria, Belgium, Denmark, France, Germany, Ireland, Luxembourg, Sweden, Switzerland, and the United Kingdom
Subscribe To Our Newsletter & Stay Updated
